Marton Laurence
SEC Form 4 insider trading activity
Marton Laurence has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 24, 2026.
On the most recent filing, Marton Laurence is listed as Director at RenovoRx, Inc. Inside the rolling window, Marton Laurence reported 1 open-market purchase in RNXT and no open-market sales.
Companies traded
Other insiders at RNXT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Marton Laurence made?
Marton Laurence has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Marton Laurence trade?
Marton Laurence has filed SEC Form 4 disclosures for 1 company, including RNXT.
When was Marton Laurence's most recent SEC Form 4 filing?
Marton Laurence's most recent SEC Form 4 filing on Tracefour is dated Mar 24, 2026.